In the present investigation, extended release tablets of metoprolol succinate were developed using cellulose derivatives and natural gums as matrix formers and were evaluated for its extended release characteristics. The optimized formulation (F7) was obtained using cellulose derivatives in the ratio of 1:0.5:1drug, HPMC K 100M and Na CMC, respectively. Prepared tablets were subjected to all the Pharmacopeial quality tests and found to be in the limits. The in vitro release studies of prepared matrix tablets with both the polymers were also studied. The kinetic treatment illustrate that the optimized formulation (F7) followed zero order kinetics with release exponent (n) 0.82 and showed good stability as per ICH guidelines. FT-IR and DSC s...
Metoprolol succinate is available in conventional dosage forms, administered four times a day, leadi...
The present work reports the study of different ketoprofen:excipient formulations, in order to deter...
It was the aim of the present study to develop sustained-release matrix tablets by means of injectio...
In the present investigation, extended release tablets of metoprolol succinate were developed using ...
Abstract The objective of this study was to design and evaluate oral sustained drug delivery system ...
ABSTRACT: The objective of the present study was to develop sustained-release matrix tablets of meto...
Objective: Metoprolol succinate is a Beta 1 selective antagonist used as an Anti hypertensive, Anti ...
Treatment of acute diseases or chronic illnesses have been mostly accomplished by delivery of drugs ...
The objective of the present study was for improving bioavailability and reducing the dosage frequen...
Objectives. The objective of this study was to investigate the possibility of developing metoprolol ...
Metoprolol succinate is a β1 selective antagonist used as an Anti-hypertensive, Anti arrhythmic, Ant...
Abstract:The objective of this study was to design and evaluate oral sustained drug delivery system ...
The objective of this study was to produce sustained-release matrix tablets by means of injection mo...
The present research work was conducted in two phases.The research work in first phase was carried o...
Sustained-release matrix tablets based on Eudragit RL and RS were manufactured by injection moulding...
Metoprolol succinate is available in conventional dosage forms, administered four times a day, leadi...
The present work reports the study of different ketoprofen:excipient formulations, in order to deter...
It was the aim of the present study to develop sustained-release matrix tablets by means of injectio...
In the present investigation, extended release tablets of metoprolol succinate were developed using ...
Abstract The objective of this study was to design and evaluate oral sustained drug delivery system ...
ABSTRACT: The objective of the present study was to develop sustained-release matrix tablets of meto...
Objective: Metoprolol succinate is a Beta 1 selective antagonist used as an Anti hypertensive, Anti ...
Treatment of acute diseases or chronic illnesses have been mostly accomplished by delivery of drugs ...
The objective of the present study was for improving bioavailability and reducing the dosage frequen...
Objectives. The objective of this study was to investigate the possibility of developing metoprolol ...
Metoprolol succinate is a β1 selective antagonist used as an Anti-hypertensive, Anti arrhythmic, Ant...
Abstract:The objective of this study was to design and evaluate oral sustained drug delivery system ...
The objective of this study was to produce sustained-release matrix tablets by means of injection mo...
The present research work was conducted in two phases.The research work in first phase was carried o...
Sustained-release matrix tablets based on Eudragit RL and RS were manufactured by injection moulding...
Metoprolol succinate is available in conventional dosage forms, administered four times a day, leadi...
The present work reports the study of different ketoprofen:excipient formulations, in order to deter...
It was the aim of the present study to develop sustained-release matrix tablets by means of injectio...